Cost-effectiveness of 12-dose LTBI regimen improved following advocacy to lower the price of rifapentine

Int J Tuberc Lung Dis. 2014 Nov;18(11):1386. doi: 10.5588/ijtld.14.0438.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / economics*
  • Drug Costs*
  • Humans
  • Isoniazid / administration & dosage*
  • Isoniazid / economics*
  • Latent Tuberculosis / drug therapy*
  • Latent Tuberculosis / economics*
  • Rifampin / analogs & derivatives*

Substances

  • Antitubercular Agents
  • Isoniazid
  • Rifampin